Catheter-based micropump for ambulatory heart failure treatment
This article was originally published in Start Up
Procyrion Inc. has developed a circulatory assist device for prolonged, ambulatory treatment of heart failure patients. Its Aortix is a micropump that is mounted on the tip of a catheter and placed nonsurgically in the descending thoracic aorta, where it reduces the heart's workload while increasing blood flow to kidneys and other organs.
You may also be interested in...
Competitive value propositions are a must in 2023 to win guarded consumers’ business. Companies that effectively address mental health and wellbeing needs and appeal to consumers through sustainability initiatives could have an edge in the recessionary environment, experts suggest. Meanwhile, there are concerns about small cosmetics companies and the availability of resources to help them comply with "modernized" federal regulations.
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.